269 related articles for article (PubMed ID: 32329874)
41. Sulforaphane alleviated vascular remodeling in hypoxic pulmonary hypertension via inhibiting inflammation and oxidative stress.
Pan J; Wang R; Pei Y; Wang D; Wu N; Ji Y; Tang Q; Liu L; Cheng K; Liu Q; Sun J; Gong M; Zheng X; Li J; Zhang C; Yuan Y
J Nutr Biochem; 2023 Jan; 111():109182. PubMed ID: 36220525
[TBL] [Abstract][Full Text] [Related]
42. Kaempferol ameliorates pulmonary vascular remodeling in chronic hypoxia-induced pulmonary hypertension rats via regulating Akt-GSK3β-cyclin axis.
Zhang X; Yang Z; Su S; Nan X; Xie X; Li Z; Lu D
Toxicol Appl Pharmacol; 2023 May; 466():116478. PubMed ID: 36940862
[TBL] [Abstract][Full Text] [Related]
43. [Hypoxia induced the remodeling of pulmonary arterial smooth muscles and increased the pulmonary artery smooth muscle Krüppel-like zinc-finger transcription factor 5 expression].
Cao MN; Chen YQ; Jiang Q; Li MC; Lu WJ; Wang J
Zhonghua Jie He He Hu Xi Za Zhi; 2016 Oct; 39(10):791-795. PubMed ID: 27784498
[No Abstract] [Full Text] [Related]
44. Hydroxysafflor yellow A (HSYA) attenuates hypoxic pulmonary arterial remodelling and reverses right ventricular hypertrophy in rats.
Li L; Dong P; Hou C; Cao F; Sun S; He F; Song Y; Li S; Bai Y; Zhu D
J Ethnopharmacol; 2016 Jun; 186():224-233. PubMed ID: 27063983
[TBL] [Abstract][Full Text] [Related]
45. Chrysin Alleviates Chronic Hypoxia-Induced Pulmonary Hypertension by Reducing Intracellular Calcium Concentration in Pulmonary Arterial Smooth Muscle Cells.
Dong F; Zhang J; Zhu S; Lan T; Yang J; Li L
J Cardiovasc Pharmacol; 2019 Nov; 74(5):426-435. PubMed ID: 31725079
[TBL] [Abstract][Full Text] [Related]
46. Beraprost Upregulates KV Channel Expression and Function via EP4 Receptor in Pulmonary Artery Smooth Muscle Cells Obtained from Rats with Hypoxia-Induced Pulmonary Hypertension.
Tian H; Fan F; Geng J; Deng J; Tian H
J Vasc Res; 2019; 56(4):204-214. PubMed ID: 31189158
[TBL] [Abstract][Full Text] [Related]
47. Role of dynorphin in hypoxic pulmonary hypertension.
Li J; Liang X; Zhou Y; Zhang S; Yang F; Guo H; Fan R; Feng N; Jia M; Wang Y; Liu M; Pei J
Eur J Pharmacol; 2016 Nov; 791():78-84. PubMed ID: 27568355
[TBL] [Abstract][Full Text] [Related]
48. MicroRNA-214-3p Regulates Hypoxia-Mediated Pulmonary Artery Smooth Muscle Cell Proliferation and Migration by Targeting ARHGEF12.
Xing XQ; Li B; Xu SL; Liu J; Zhang CF; Yang J
Med Sci Monit; 2019 Aug; 25():5738-5746. PubMed ID: 31373336
[TBL] [Abstract][Full Text] [Related]
49. Micro-RNA-1 is decreased by hypoxia and contributes to the development of pulmonary vascular remodeling via regulation of sphingosine kinase 1.
Sysol JR; Chen J; Singla S; Zhao S; Comhair S; Natarajan V; Machado RF
Am J Physiol Lung Cell Mol Physiol; 2018 Mar; 314(3):L461-L472. PubMed ID: 29167124
[TBL] [Abstract][Full Text] [Related]
50. Calcineurin/NFAT Signaling Modulates Pulmonary Artery Smooth Muscle Cell Proliferation, Migration and Apoptosis in Monocrotaline-Induced Pulmonary Arterial Hypertension Rats.
He RL; Wu ZJ; Liu XR; Gui LX; Wang RX; Lin MJ
Cell Physiol Biochem; 2018; 49(1):172-189. PubMed ID: 30134231
[TBL] [Abstract][Full Text] [Related]
51. LncRNA Tug1 involves in the pulmonary vascular remodeling in mice with hypoxic pulmonary hypertension via the microRNA-374c-mediated Foxc1.
Yang L; Liang H; Shen L; Guan Z; Meng X
Life Sci; 2019 Nov; 237():116769. PubMed ID: 31422096
[TBL] [Abstract][Full Text] [Related]
52. The potential of asiaticoside for TGF-β1/Smad signaling inhibition in prevention and progression of hypoxia-induced pulmonary hypertension.
Wang XB; Wang W; Zhu XC; Ye WJ; Cai H; Wu PL; Huang XY; Wang LX
Life Sci; 2015 Sep; 137():56-64. PubMed ID: 26209140
[TBL] [Abstract][Full Text] [Related]
53. Notch3 signaling activation in smooth muscle cells promotes extrauterine growth restriction-induced pulmonary hypertension.
Wang Y; Dai S; Cheng X; Prado E; Yan L; Hu J; He Q; Lv Y; Lv Y; Du L
Nutr Metab Cardiovasc Dis; 2019 Jun; 29(6):639-651. PubMed ID: 30954415
[TBL] [Abstract][Full Text] [Related]
54. Stox1 induced the proliferation and cell cycle arrest in pulmonary artery smooth muscle cells via AKT signaling pathway.
Xu Y; Sun Z; Wang Q; Wang T; Liu Y; Yu F
Vascul Pharmacol; 2019 Sep; 120():106568. PubMed ID: 31207359
[TBL] [Abstract][Full Text] [Related]
55. Transgelin as a therapeutic target to prevent hypoxic pulmonary hypertension.
Zhang R; Shi L; Zhou L; Zhang G; Wu X; Shao F; Ma G; Ying K
Am J Physiol Lung Cell Mol Physiol; 2014 Mar; 306(6):L574-83. PubMed ID: 24464808
[TBL] [Abstract][Full Text] [Related]
56. The effect of activated κ-opioid receptor (κ-OR) on the role of calcium sensing receptor (CaSR) in preventing hypoxic pulmonary hypertension development.
Li J; Jia M; Liu M; Cao Z; Wang X; Feng N; Gu X; Zhang S; Fan R; Guo H; Wang Y; Liu M; Pei J
Biomed Pharmacother; 2020 May; 125():109931. PubMed ID: 32066040
[TBL] [Abstract][Full Text] [Related]
57. Losartan attenuates chronic cigarette smoke exposure-induced pulmonary arterial hypertension in rats: possible involvement of angiotensin-converting enzyme-2.
Han SX; He GM; Wang T; Chen L; Ning YY; Luo F; An J; Yang T; Dong JJ; Liao ZL; Xu D; Wen FQ
Toxicol Appl Pharmacol; 2010 May; 245(1):100-7. PubMed ID: 20178811
[TBL] [Abstract][Full Text] [Related]
58. Knockdown of HSP110 attenuates hypoxia-induced pulmonary hypertension in mice through suppression of YAP/TAZ-TEAD4 pathway.
Liu H; Zhang S; Liu Y; Ma J; Chen W; Yin T; Li T; Liang B; Tao L
Respir Res; 2022 Aug; 23(1):209. PubMed ID: 35986277
[TBL] [Abstract][Full Text] [Related]
59. [Effects of typical PKC subtypes on the proliferation of mouse pulmonary artery smooth muscle cells and the expression of ERK1/2 and Akt induced by hypoxia].
Shi YW; Qin XJ; Zeng C; Zhang XR
Zhonghua Jie He He Hu Xi Za Zhi; 2022 May; 45(5):460-467. PubMed ID: 35527461
[No Abstract] [Full Text] [Related]
60. Methylation-mediated silencing of PTPRD induces pulmonary hypertension by promoting pulmonary arterial smooth muscle cell migration via the PDGFRB/PLCγ1 axis.
Xu J; Zhong Y; Yin H; Linneman J; Luo Y; Xia S; Xia Q; Yang L; Huang X; Kang K; Wang J; Niu Y; Li L; Gou D
J Hypertens; 2022 Sep; 40(9):1795-1807. PubMed ID: 35848503
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
